Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast vs Fluticasone in Pre-School Asthma
NCT00543686Phase 2Completed
- Sponsor
- Universitätsklinikum Frankfurt
- Start
- Aug 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of montelukast in asthma (2 arms), sponsored by Universitätsklinikum Frankfurt. Primary endpoint: Number of responders with a very good asthma symptom control defined as requiring no rapid acting beta agonist (RABA) at 6 weeks. Started Aug 2007; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00543686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543686.